Novo Nordisk is committed to meeting its responsibility to respect human rights as defined by the UN Guiding Principles on Business and Human Rights. As such we will:
- Identify potential and actual adverse human rights impacts that our operations may cause, contribute to or be directly linked to;
- Establish processes to prevent or mitigate potential adverse impacts on human rights, where identified; Seek to best remediate or participate in the remediation of any actual adverse human rights impacts that our business causes or contributes to;
- Account for how we address our potential and actual impacts on human rights, where it will not put the people concerned at risk or damage legitimate requirements of commercial confidentiality;
- Expect our business partners and other parties directly linked to our operations, products or services to respect human rights as described by the UN Guiding Principles on Business and Human Rights; including committing to respect human rights, carrying out human rights due diligence and providing access to remedy when needed;
- Use leverage to make other parties directly linked to our operations, products or services cease actions or omissions that lead to adverse impacts on human rights, once we become aware of such impact.
- We expect every employee to ‘Treat everyone with respect’, according to the company values expressed in Novo Nordisk Way
In implementing the UN Guiding Principles in a non-discriminatory manner, we will pay particular attention to the rights of, as well as the challenges faced by, vulnerable groups, such as children and indigenous people, and the different risks that may be faced by women and men.
In addition to working with respect for human rights, we pursue opportunities to support human rights where we can make a positive impact.
Approval by Social and Environmental Committee acting with a mandate from the Executive Management on 27 November 2014.